The particulars: deamidation · semaglutide · Medutest.
I have read the obvious sources and they disagree with each other, so I would rather ask people who have actually done this.
I have a working setup and a notebook, and I am prepared to be told that my setup is inadequate if that is the answer.
Which parts of this are load-bearing and which parts are habit?
The short version: intact crimp, seated stopper, legible lot code, and a cake that looks like a cake.
Look for fibres, glass fragments and dark particulate in the cake. Glass is the one that matters and is usually a crimping or handling artefact rather than a synthesis one.
| Configuration | Dead volume | Loss at 5 mg/mL | Over 20 draws |
|---|---|---|---|
| Fixed-needle insulin syringe | 3–5 µL | 15–25 µg | 0.3–0.5 mg |
| Low-dead-space, detachable | <2 µL | <10 µg | <0.2 mg |
| Standard luer-lock + 30G | 35–60 µL | 175–300 µg | 3.5–6 mg |
| Luer-lock + 21G drawing needle | 70–100 µL | 350–500 µg | 7–10 mg |
Check the fill looks proportionate to the label claim. Ten milligrams of peptide is a small volume of powder, but it is not nothing, and a vial that looks empty is worth a photograph.
The caveat is that inspection cannot detect identity, purity, content or endotoxin, which are the things most likely to be wrong.
Inspect before reconstitution. Afterwards you cannot tell whose particle it is.
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsTo be exact about it, the lot code on the vial, not on the box, is what ties your material to a certificate.
Confirm the lot code is physically on the vial and legible, and that it matches the certificate and the invoice. A code on the box only ties a certificate to a box.
After reconstitution, hold against a light and look for haze, floaters or a Tyndall effect. A clear solution that goes clear on contact is what a well-made preparation looks like.
Visual inspection for particulate matter is a pharmacopoeial requirement for parenteral products and the standard technique uses both light and dark backgrounds.
A vial that passes inspection has passed a very weak test. It has not been verified.
Passing inspection is a weak result. It rules out the obvious and nothing else.
Answer first: inspect before you reconstitute, because after reconstitution you cannot distinguish a particle that arrived with the powder from one you introduced.
Weigh the vial if you have a scale reading to a milligram. It will not give you content, but a vial several tens of milligrams lighter than its siblings is a fill problem.
Inspect the powder against both a white and a black background under good light. Discolouration, browning or a yellow tinge on a peptide that should be white is worth photographing before doing anything else.
Photograph anything unexpected before touching it further.
Start with the seal, the stopper and the label, in that order, and then look at the contents against a light and a dark background.
Check the aluminium crimp is fully seated with no lift at the edge, the flip-off cap has not been previously removed, and the stopper sits flush without a visible gap or dimple.
Melt-back and collapse are documented lyophilisation cycle defects with well-described visual appearances.
Crimp, stopper, label, contents. Light background and dark background.
edited 22 Apr 2025 by lyoph_cake — updated for the 2026 guidance change
The relevant principle is that anything you find before reconstitution is the supplier's, and anything you find after might be yours.
Melt-back at the stopper — a glassy ring where the cake meets the closure — indicates the cycle ran warm at the top of the vial. Cosmetic in most cases, informative always.
Lot traceability to the primary container rather than to secondary packaging is a basic requirement of any documentation system worth the name.
Nothing here is medical advice, and research-use compounds are not approved for human use.
The lot code has to be on the vial. A code on the box ties nothing to anything.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.